US’ Precipio signs services contract with Egyptian hospitals

US-based cancer diagnostics firm Precipio announced last week it has signed a services contract with several unnamed hospitals in Cairo that could be worth more than USD 1.5 mn, reports Proactive Investors. The contracts will see the establishment of “laboratory operations in Egypt that will license Precipio’s proprietary technologies to provide liquid biopsy testing.”